Lysimax

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	20-08-2025	20 d late	2025-00412821
31-12-2023	31-07-2024	14-03-2024	139 d early	2024-00044196

Metric	This company	Sector median	Position in the sector
Solvency	-2.1%	19.3%	better than 30% of 5615 sector peers
Net result	€-20k	€4k	better than 14% of 5603 sector peers
Equity	€-4k	€14k	better than 27% of 5626 sector peers
Gross operating margin	€133k	€52k	better than 76% of 5589 sector peers
Staff costs	€111k	€49k	higher than 74% of 4064 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€169k
Fixed assets	21/28	€134k
Tangible fixed assets	22/27	€133k
Financial fixed assets	28	€363
Current assets	29/58	€35k
Stocks & contracts in progress	3	€18k
Amounts receivable within one year	40/41	€7k
Cash & bank	54/58	€4k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€169k
Equity	10/15	€-4k
Contributions / capital	10/11	€6k
Accumulated profits (losses)	14	€-10k
Amounts payable	17/49	€172k
Amounts payable after one year	17	€64k
Amounts payable within one year	42/48	€108k
Trade debts payable within one year	44	€59k
Income statement
Gross operating margin	9900	€133k
Operating result	9901	€-7k
Financial income	75	€10
Financial charges	65	€13k
Result before taxes	9903	€-20k
Net result for the period	9904	€-20k
Result to be appropriated	9905	€-20k

Summary